We love mRNA!
The BASE mRNA Facility was founded in 2021 with a mission to provide Australian scientists with rapid and reliable access to high-quality and affordable mRNA.
We help scientists build the next-generation of mRNA vaccines and therapies to treat disease.
The BASE facility is a non-profit facility supported by The University of Queensland (UQ) and Therapeutics Innovation Australia (TIA, NCRIS).
The BASE Research laboratories are located at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, St Lucia, Brisbane.
We have experience in the discovery and development of novel mRNA vaccines and therapies.
We lead research programs in advanced manufacturing, process development, and development of mRNA platform technologies.
The new BASE production facilities opened at the Translational Research Institute (TRI) in 2024.
These state-of-art facilities can produce mRNA and LNP at large scales, and are supported by detailed quality control analysis.
Our production team can deliver high-quality mRNA and LNP formulations according to specification.
Our support team is available to help with your mRNA projects.
